nodes	percent_of_prediction	percent_of_DWPC	metapath
Sertraline—CYP2D6—Hydroxyurea—head and neck cancer	0.186	0.3	CbGbCtD
Sertraline—CYP1A2—Fluorouracil—head and neck cancer	0.0864	0.139	CbGbCtD
Sertraline—CYP2C9—Fluorouracil—head and neck cancer	0.0779	0.125	CbGbCtD
Sertraline—ABCB1—Vinblastine—head and neck cancer	0.07	0.113	CbGbCtD
Sertraline—CYP2D6—Vinblastine—head and neck cancer	0.066	0.106	CbGbCtD
Sertraline—ABCB1—Docetaxel—head and neck cancer	0.0577	0.0929	CbGbCtD
Sertraline—CYP3A4—Vinblastine—head and neck cancer	0.042	0.0676	CbGbCtD
Sertraline—CYP3A4—Docetaxel—head and neck cancer	0.0346	0.0557	CbGbCtD
Sertraline—Dysuria—Hydroxyurea—head and neck cancer	0.00165	0.00489	CcSEcCtD
Sertraline—Agranulocytosis—Vinblastine—head and neck cancer	0.00161	0.00477	CcSEcCtD
Sertraline—Weight increased—Hydroxyurea—head and neck cancer	0.00161	0.00476	CcSEcCtD
Sertraline—Oliguria—Docetaxel—head and neck cancer	0.00159	0.0047	CcSEcCtD
Sertraline—Drowsiness—Hydroxyurea—head and neck cancer	0.00158	0.00466	CcSEcCtD
Sertraline—Amnesia—Fluorouracil—head and neck cancer	0.00157	0.00464	CcSEcCtD
Sertraline—Haemoglobin—Vinblastine—head and neck cancer	0.00156	0.00461	CcSEcCtD
Sertraline—Haemorrhage—Vinblastine—head and neck cancer	0.00155	0.00459	CcSEcCtD
Sertraline—Blood bilirubin increased—Docetaxel—head and neck cancer	0.00155	0.00458	CcSEcCtD
Sertraline—Neuropathy peripheral—Hydroxyurea—head and neck cancer	0.00154	0.00457	CcSEcCtD
Sertraline—Hypoaesthesia—Vinblastine—head and neck cancer	0.00154	0.00457	CcSEcCtD
Sertraline—Dermatitis bullous—Fluorouracil—head and neck cancer	0.00154	0.00456	CcSEcCtD
Sertraline—Pharyngitis—Vinblastine—head and neck cancer	0.00154	0.00456	CcSEcCtD
Sertraline—Stomatitis—Hydroxyurea—head and neck cancer	0.00154	0.00455	CcSEcCtD
Sertraline—Hepatobiliary disease—Hydroxyurea—head and neck cancer	0.00149	0.00441	CcSEcCtD
Sertraline—Respiratory failure—Docetaxel—head and neck cancer	0.00149	0.00441	CcSEcCtD
Sertraline—Osteoarthritis—Fluorouracil—head and neck cancer	0.00147	0.00436	CcSEcCtD
Sertraline—Gastrointestinal haemorrhage—Fluorouracil—head and neck cancer	0.00147	0.00436	CcSEcCtD
Sertraline—Phosphatase alkaline increased—Docetaxel—head and neck cancer	0.00146	0.00433	CcSEcCtD
Sertraline—Haemoglobin—Hydroxyurea—head and neck cancer	0.00142	0.00421	CcSEcCtD
Sertraline—Haemorrhage—Hydroxyurea—head and neck cancer	0.00141	0.00419	CcSEcCtD
Sertraline—Hallucination—Hydroxyurea—head and neck cancer	0.00141	0.00417	CcSEcCtD
Sertraline—Colitis—Docetaxel—head and neck cancer	0.0014	0.00416	CcSEcCtD
Sertraline—Fluid retention—Docetaxel—head and neck cancer	0.00139	0.00411	CcSEcCtD
Sertraline—Ataxia—Fluorouracil—head and neck cancer	0.00138	0.0041	CcSEcCtD
Sertraline—Alopecia—Vinblastine—head and neck cancer	0.00137	0.00406	CcSEcCtD
Sertraline—Dry skin—Fluorouracil—head and neck cancer	0.00135	0.00399	CcSEcCtD
Sertraline—Oesophagitis—Docetaxel—head and neck cancer	0.00134	0.00396	CcSEcCtD
Sertraline—Neoplasm—Docetaxel—head and neck cancer	0.00132	0.00392	CcSEcCtD
Sertraline—Muscular weakness—Fluorouracil—head and neck cancer	0.0013	0.00384	CcSEcCtD
Sertraline—Angiopathy—Hydroxyurea—head and neck cancer	0.00128	0.0038	CcSEcCtD
Sertraline—Dysphagia—Fluorouracil—head and neck cancer	0.00127	0.00376	CcSEcCtD
Sertraline—Chills—Hydroxyurea—head and neck cancer	0.00127	0.00376	CcSEcCtD
Sertraline—Ill-defined disorder—Vinblastine—head and neck cancer	0.00125	0.00371	CcSEcCtD
Sertraline—Alopecia—Hydroxyurea—head and neck cancer	0.00125	0.0037	CcSEcCtD
Sertraline—Anaemia—Vinblastine—head and neck cancer	0.00125	0.00369	CcSEcCtD
Sertraline—Erythema—Hydroxyurea—head and neck cancer	0.00123	0.00364	CcSEcCtD
Sertraline—Blood alkaline phosphatase increased—Docetaxel—head and neck cancer	0.00122	0.00361	CcSEcCtD
Sertraline—Malaise—Vinblastine—head and neck cancer	0.00122	0.0036	CcSEcCtD
Sertraline—Vertigo—Vinblastine—head and neck cancer	0.00121	0.00359	CcSEcCtD
Sertraline—Leukopenia—Vinblastine—head and neck cancer	0.00121	0.00358	CcSEcCtD
Sertraline—Pancytopenia—Fluorouracil—head and neck cancer	0.00121	0.00358	CcSEcCtD
Sertraline—Upper respiratory tract infection—Fluorouracil—head and neck cancer	0.00118	0.0035	CcSEcCtD
Sertraline—Hepatic failure—Docetaxel—head and neck cancer	0.00118	0.0035	CcSEcCtD
Sertraline—Convulsion—Vinblastine—head and neck cancer	0.00117	0.00346	CcSEcCtD
Sertraline—Hypertension—Vinblastine—head and neck cancer	0.00117	0.00345	CcSEcCtD
Sertraline—Photosensitivity reaction—Fluorouracil—head and neck cancer	0.00116	0.00344	CcSEcCtD
Sertraline—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.00114	0.00338	CcSEcCtD
Sertraline—Anaemia—Hydroxyurea—head and neck cancer	0.00114	0.00337	CcSEcCtD
Sertraline—Discomfort—Vinblastine—head and neck cancer	0.00114	0.00336	CcSEcCtD
Sertraline—Hot flush—Docetaxel—head and neck cancer	0.00114	0.00336	CcSEcCtD
Sertraline—Menopausal symptoms—Docetaxel—head and neck cancer	0.00113	0.00333	CcSEcCtD
Sertraline—Acute coronary syndrome—Fluorouracil—head and neck cancer	0.00112	0.00331	CcSEcCtD
Sertraline—Myocardial infarction—Fluorouracil—head and neck cancer	0.00111	0.00329	CcSEcCtD
Sertraline—Neuropathy peripheral—Fluorouracil—head and neck cancer	0.00111	0.00329	CcSEcCtD
Sertraline—Dermatitis bullous—Docetaxel—head and neck cancer	0.00111	0.00329	CcSEcCtD
Sertraline—Malaise—Hydroxyurea—head and neck cancer	0.00111	0.00329	CcSEcCtD
Sertraline—Stomatitis—Fluorouracil—head and neck cancer	0.00111	0.00327	CcSEcCtD
Sertraline—Conjunctivitis—Fluorouracil—head and neck cancer	0.0011	0.00326	CcSEcCtD
Sertraline—Leukopenia—Hydroxyurea—head and neck cancer	0.0011	0.00326	CcSEcCtD
Sertraline—Thrombocytopenia—Vinblastine—head and neck cancer	0.00108	0.00319	CcSEcCtD
Sertraline—Epistaxis—Fluorouracil—head and neck cancer	0.00107	0.00317	CcSEcCtD
Sertraline—Convulsion—Hydroxyurea—head and neck cancer	0.00107	0.00316	CcSEcCtD
Sertraline—Hyponatraemia—Docetaxel—head and neck cancer	0.00107	0.00316	CcSEcCtD
Sertraline—Sinusitis—Fluorouracil—head and neck cancer	0.00106	0.00315	CcSEcCtD
Sertraline—Gastrointestinal haemorrhage—Docetaxel—head and neck cancer	0.00106	0.00314	CcSEcCtD
Sertraline—Agranulocytosis—Fluorouracil—head and neck cancer	0.00106	0.00313	CcSEcCtD
Sertraline—Anorexia—Vinblastine—head and neck cancer	0.00105	0.00311	CcSEcCtD
Sertraline—Migraine—Docetaxel—head and neck cancer	0.00105	0.00309	CcSEcCtD
Sertraline—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.00104	0.00308	CcSEcCtD
Sertraline—Discomfort—Hydroxyurea—head and neck cancer	0.00104	0.00307	CcSEcCtD
Sertraline—Haemoglobin—Fluorouracil—head and neck cancer	0.00102	0.00303	CcSEcCtD
Sertraline—Rhinitis—Fluorouracil—head and neck cancer	0.00102	0.00302	CcSEcCtD
Sertraline—Haemorrhage—Fluorouracil—head and neck cancer	0.00102	0.00301	CcSEcCtD
Sertraline—Hypoaesthesia—Fluorouracil—head and neck cancer	0.00101	0.003	CcSEcCtD
Sertraline—Pharyngitis—Fluorouracil—head and neck cancer	0.00101	0.00299	CcSEcCtD
Sertraline—Oedema—Hydroxyurea—head and neck cancer	0.001	0.00297	CcSEcCtD
Sertraline—Ataxia—Docetaxel—head and neck cancer	0.000999	0.00296	CcSEcCtD
Sertraline—Paraesthesia—Vinblastine—head and neck cancer	0.000989	0.00293	CcSEcCtD
Sertraline—Dehydration—Docetaxel—head and neck cancer	0.000988	0.00292	CcSEcCtD
Sertraline—Nervous system disorder—Hydroxyurea—head and neck cancer	0.000985	0.00292	CcSEcCtD
Sertraline—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.000984	0.00291	CcSEcCtD
Sertraline—Skin disorder—Hydroxyurea—head and neck cancer	0.000976	0.00289	CcSEcCtD
Sertraline—Dry skin—Docetaxel—head and neck cancer	0.000973	0.00288	CcSEcCtD
Sertraline—Orthostatic hypotension—Docetaxel—head and neck cancer	0.00097	0.00287	CcSEcCtD
Sertraline—Breast disorder—Docetaxel—head and neck cancer	0.00096	0.00284	CcSEcCtD
Sertraline—Anorexia—Hydroxyurea—head and neck cancer	0.000958	0.00284	CcSEcCtD
Sertraline—Decreased appetite—Vinblastine—head and neck cancer	0.000958	0.00284	CcSEcCtD
Sertraline—Cramp muscle—Docetaxel—head and neck cancer	0.000956	0.00283	CcSEcCtD
Sertraline—Toxic epidermal necrolysis—Docetaxel—head and neck cancer	0.000956	0.00283	CcSEcCtD
Sertraline—Pain—Vinblastine—head and neck cancer	0.000942	0.00279	CcSEcCtD
Sertraline—Constipation—Vinblastine—head and neck cancer	0.000942	0.00279	CcSEcCtD
Sertraline—Alanine aminotransferase increased—Docetaxel—head and neck cancer	0.000937	0.00277	CcSEcCtD
Sertraline—Dysphagia—Docetaxel—head and neck cancer	0.000918	0.00272	CcSEcCtD
Sertraline—Arrhythmia—Fluorouracil—head and neck cancer	0.000909	0.00269	CcSEcCtD
Sertraline—Feeling abnormal—Vinblastine—head and neck cancer	0.000908	0.00269	CcSEcCtD
Sertraline—Bronchospasm—Docetaxel—head and neck cancer	0.000903	0.00267	CcSEcCtD
Sertraline—Gastrointestinal pain—Vinblastine—head and neck cancer	0.000901	0.00267	CcSEcCtD
Sertraline—Alopecia—Fluorouracil—head and neck cancer	0.0009	0.00266	CcSEcCtD
Sertraline—Dyspnoea—Hydroxyurea—head and neck cancer	0.000896	0.00265	CcSEcCtD
Sertraline—Somnolence—Hydroxyurea—head and neck cancer	0.000893	0.00264	CcSEcCtD
Sertraline—Erythema—Fluorouracil—head and neck cancer	0.000886	0.00262	CcSEcCtD
Sertraline—Dyspepsia—Hydroxyurea—head and neck cancer	0.000884	0.00262	CcSEcCtD
Sertraline—Decreased appetite—Hydroxyurea—head and neck cancer	0.000873	0.00259	CcSEcCtD
Sertraline—Pancytopenia—Docetaxel—head and neck cancer	0.000872	0.00258	CcSEcCtD
Sertraline—Abdominal pain—Vinblastine—head and neck cancer	0.000871	0.00258	CcSEcCtD
Sertraline—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.000867	0.00257	CcSEcCtD
Sertraline—Fatigue—Hydroxyurea—head and neck cancer	0.000866	0.00256	CcSEcCtD
Sertraline—Pain—Hydroxyurea—head and neck cancer	0.000859	0.00254	CcSEcCtD
Sertraline—Constipation—Hydroxyurea—head and neck cancer	0.000859	0.00254	CcSEcCtD
Sertraline—Weight increased—Docetaxel—head and neck cancer	0.000835	0.00247	CcSEcCtD
Sertraline—Weight decreased—Docetaxel—head and neck cancer	0.00083	0.00246	CcSEcCtD
Sertraline—Feeling abnormal—Hydroxyurea—head and neck cancer	0.000828	0.00245	CcSEcCtD
Sertraline—Anaemia—Fluorouracil—head and neck cancer	0.000819	0.00242	CcSEcCtD
Sertraline—Hypersensitivity—Vinblastine—head and neck cancer	0.000812	0.0024	CcSEcCtD
Sertraline—Stevens-Johnson syndrome—Docetaxel—head and neck cancer	0.000811	0.0024	CcSEcCtD
Sertraline—Acute coronary syndrome—Docetaxel—head and neck cancer	0.000807	0.00239	CcSEcCtD
Sertraline—Myocardial infarction—Docetaxel—head and neck cancer	0.000802	0.00237	CcSEcCtD
Sertraline—Neuropathy peripheral—Docetaxel—head and neck cancer	0.000802	0.00237	CcSEcCtD
Sertraline—Stomatitis—Docetaxel—head and neck cancer	0.000798	0.00236	CcSEcCtD
Sertraline—Jaundice—Docetaxel—head and neck cancer	0.000798	0.00236	CcSEcCtD
Sertraline—Conjunctivitis—Docetaxel—head and neck cancer	0.000796	0.00236	CcSEcCtD
Sertraline—Body temperature increased—Hydroxyurea—head and neck cancer	0.000794	0.00235	CcSEcCtD
Sertraline—Leukopenia—Fluorouracil—head and neck cancer	0.000793	0.00235	CcSEcCtD
Sertraline—Asthenia—Vinblastine—head and neck cancer	0.00079	0.00234	CcSEcCtD
Sertraline—Hepatobiliary disease—Docetaxel—head and neck cancer	0.000774	0.00229	CcSEcCtD
Sertraline—Epistaxis—Docetaxel—head and neck cancer	0.000772	0.00229	CcSEcCtD
Sertraline—Convulsion—Fluorouracil—head and neck cancer	0.000768	0.00227	CcSEcCtD
Sertraline—Agranulocytosis—Docetaxel—head and neck cancer	0.000764	0.00226	CcSEcCtD
Sertraline—Chest pain—Fluorouracil—head and neck cancer	0.000754	0.00223	CcSEcCtD
Sertraline—Myalgia—Fluorouracil—head and neck cancer	0.000754	0.00223	CcSEcCtD
Sertraline—Diarrhoea—Vinblastine—head and neck cancer	0.000754	0.00223	CcSEcCtD
Sertraline—Discomfort—Fluorouracil—head and neck cancer	0.000745	0.00221	CcSEcCtD
Sertraline—Hypersensitivity—Hydroxyurea—head and neck cancer	0.00074	0.00219	CcSEcCtD
Sertraline—Haemoglobin—Docetaxel—head and neck cancer	0.000738	0.00219	CcSEcCtD
Sertraline—Rhinitis—Docetaxel—head and neck cancer	0.000737	0.00218	CcSEcCtD
Sertraline—Haemorrhage—Docetaxel—head and neck cancer	0.000735	0.00218	CcSEcCtD
Sertraline—Hepatitis—Docetaxel—head and neck cancer	0.000735	0.00218	CcSEcCtD
Sertraline—Hypoaesthesia—Docetaxel—head and neck cancer	0.000731	0.00216	CcSEcCtD
Sertraline—Confusional state—Fluorouracil—head and neck cancer	0.000729	0.00216	CcSEcCtD
Sertraline—Pharyngitis—Docetaxel—head and neck cancer	0.000729	0.00216	CcSEcCtD
Sertraline—Dizziness—Vinblastine—head and neck cancer	0.000729	0.00216	CcSEcCtD
Sertraline—Urinary tract disorder—Docetaxel—head and neck cancer	0.000726	0.00215	CcSEcCtD
Sertraline—Oedema peripheral—Docetaxel—head and neck cancer	0.000724	0.00214	CcSEcCtD
Sertraline—Anaphylactic shock—Fluorouracil—head and neck cancer	0.000723	0.00214	CcSEcCtD
Sertraline—Oedema—Fluorouracil—head and neck cancer	0.000723	0.00214	CcSEcCtD
Sertraline—Connective tissue disorder—Docetaxel—head and neck cancer	0.000722	0.00214	CcSEcCtD
Sertraline—Asthenia—Hydroxyurea—head and neck cancer	0.000721	0.00213	CcSEcCtD
Sertraline—Urethral disorder—Docetaxel—head and neck cancer	0.00072	0.00213	CcSEcCtD
Sertraline—Nervous system disorder—Fluorouracil—head and neck cancer	0.000709	0.0021	CcSEcCtD
Sertraline—Thrombocytopenia—Fluorouracil—head and neck cancer	0.000708	0.0021	CcSEcCtD
Sertraline—Visual impairment—Docetaxel—head and neck cancer	0.000708	0.0021	CcSEcCtD
Sertraline—Tachycardia—Fluorouracil—head and neck cancer	0.000706	0.00209	CcSEcCtD
Sertraline—Vomiting—Vinblastine—head and neck cancer	0.0007	0.00207	CcSEcCtD
Sertraline—Erythema multiforme—Docetaxel—head and neck cancer	0.000695	0.00206	CcSEcCtD
Sertraline—Headache—Vinblastine—head and neck cancer	0.00069	0.00204	CcSEcCtD
Sertraline—Anorexia—Fluorouracil—head and neck cancer	0.000689	0.00204	CcSEcCtD
Sertraline—Diarrhoea—Hydroxyurea—head and neck cancer	0.000687	0.00204	CcSEcCtD
Sertraline—Eye disorder—Docetaxel—head and neck cancer	0.000687	0.00203	CcSEcCtD
Sertraline—Flushing—Docetaxel—head and neck cancer	0.000682	0.00202	CcSEcCtD
Sertraline—Cardiac disorder—Docetaxel—head and neck cancer	0.000682	0.00202	CcSEcCtD
Sertraline—Hypotension—Fluorouracil—head and neck cancer	0.000676	0.002	CcSEcCtD
Sertraline—Angiopathy—Docetaxel—head and neck cancer	0.000667	0.00197	CcSEcCtD
Sertraline—Dizziness—Hydroxyurea—head and neck cancer	0.000664	0.00197	CcSEcCtD
Sertraline—Immune system disorder—Docetaxel—head and neck cancer	0.000664	0.00196	CcSEcCtD
Sertraline—Mediastinal disorder—Docetaxel—head and neck cancer	0.000662	0.00196	CcSEcCtD
Sertraline—Chills—Docetaxel—head and neck cancer	0.000659	0.00195	CcSEcCtD
Sertraline—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.000659	0.00195	CcSEcCtD
Sertraline—Arrhythmia—Docetaxel—head and neck cancer	0.000656	0.00194	CcSEcCtD
Sertraline—Nausea—Vinblastine—head and neck cancer	0.000654	0.00194	CcSEcCtD
Sertraline—Insomnia—Fluorouracil—head and neck cancer	0.000654	0.00194	CcSEcCtD
Sertraline—Paraesthesia—Fluorouracil—head and neck cancer	0.000649	0.00192	CcSEcCtD
Sertraline—Alopecia—Docetaxel—head and neck cancer	0.000649	0.00192	CcSEcCtD
Sertraline—Dyspnoea—Fluorouracil—head and neck cancer	0.000645	0.00191	CcSEcCtD
Sertraline—Mental disorder—Docetaxel—head and neck cancer	0.000644	0.00191	CcSEcCtD
Sertraline—Somnolence—Fluorouracil—head and neck cancer	0.000643	0.0019	CcSEcCtD
Sertraline—Erythema—Docetaxel—head and neck cancer	0.00064	0.00189	CcSEcCtD
Sertraline—Malnutrition—Docetaxel—head and neck cancer	0.00064	0.00189	CcSEcCtD
Sertraline—Vomiting—Hydroxyurea—head and neck cancer	0.000639	0.00189	CcSEcCtD
Sertraline—Dyspepsia—Fluorouracil—head and neck cancer	0.000637	0.00188	CcSEcCtD
Sertraline—Rash—Hydroxyurea—head and neck cancer	0.000634	0.00188	CcSEcCtD
Sertraline—Dermatitis—Hydroxyurea—head and neck cancer	0.000633	0.00187	CcSEcCtD
Sertraline—Headache—Hydroxyurea—head and neck cancer	0.000629	0.00186	CcSEcCtD
Sertraline—Decreased appetite—Fluorouracil—head and neck cancer	0.000629	0.00186	CcSEcCtD
Sertraline—Dysgeusia—Docetaxel—head and neck cancer	0.000626	0.00185	CcSEcCtD
Sertraline—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.000624	0.00185	CcSEcCtD
Sertraline—Back pain—Docetaxel—head and neck cancer	0.000619	0.00183	CcSEcCtD
Sertraline—Pain—Fluorouracil—head and neck cancer	0.000618	0.00183	CcSEcCtD
Sertraline—Muscle spasms—Docetaxel—head and neck cancer	0.000615	0.00182	CcSEcCtD
Sertraline—Nausea—Hydroxyurea—head and neck cancer	0.000597	0.00177	CcSEcCtD
Sertraline—Feeling abnormal—Fluorouracil—head and neck cancer	0.000596	0.00176	CcSEcCtD
Sertraline—Anaemia—Docetaxel—head and neck cancer	0.000591	0.00175	CcSEcCtD
Sertraline—Urticaria—Fluorouracil—head and neck cancer	0.000575	0.0017	CcSEcCtD
Sertraline—Syncope—Docetaxel—head and neck cancer	0.000574	0.0017	CcSEcCtD
Sertraline—Leukopenia—Docetaxel—head and neck cancer	0.000572	0.00169	CcSEcCtD
Sertraline—Body temperature increased—Fluorouracil—head and neck cancer	0.000572	0.00169	CcSEcCtD
Sertraline—Palpitations—Docetaxel—head and neck cancer	0.000565	0.00167	CcSEcCtD
Sertraline—Loss of consciousness—Docetaxel—head and neck cancer	0.000562	0.00166	CcSEcCtD
Sertraline—Cough—Docetaxel—head and neck cancer	0.000558	0.00165	CcSEcCtD
Sertraline—Convulsion—Docetaxel—head and neck cancer	0.000554	0.00164	CcSEcCtD
Sertraline—Hypertension—Docetaxel—head and neck cancer	0.000552	0.00163	CcSEcCtD
Sertraline—Arthralgia—Docetaxel—head and neck cancer	0.000545	0.00161	CcSEcCtD
Sertraline—Myalgia—Docetaxel—head and neck cancer	0.000545	0.00161	CcSEcCtD
Sertraline—Chest pain—Docetaxel—head and neck cancer	0.000545	0.00161	CcSEcCtD
Sertraline—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.000541	0.0016	CcSEcCtD
Sertraline—Hypersensitivity—Fluorouracil—head and neck cancer	0.000533	0.00158	CcSEcCtD
Sertraline—Dry mouth—Docetaxel—head and neck cancer	0.000533	0.00158	CcSEcCtD
Sertraline—Confusional state—Docetaxel—head and neck cancer	0.000526	0.00156	CcSEcCtD
Sertraline—Oedema—Docetaxel—head and neck cancer	0.000522	0.00155	CcSEcCtD
Sertraline—Anaphylactic shock—Docetaxel—head and neck cancer	0.000522	0.00155	CcSEcCtD
Sertraline—Shock—Docetaxel—head and neck cancer	0.000514	0.00152	CcSEcCtD
Sertraline—Nervous system disorder—Docetaxel—head and neck cancer	0.000512	0.00152	CcSEcCtD
Sertraline—Pruritus—Fluorouracil—head and neck cancer	0.000512	0.00151	CcSEcCtD
Sertraline—Thrombocytopenia—Docetaxel—head and neck cancer	0.000511	0.00151	CcSEcCtD
Sertraline—Tachycardia—Docetaxel—head and neck cancer	0.000509	0.00151	CcSEcCtD
Sertraline—Skin disorder—Docetaxel—head and neck cancer	0.000507	0.0015	CcSEcCtD
Sertraline—Anorexia—Docetaxel—head and neck cancer	0.000498	0.00147	CcSEcCtD
Sertraline—Diarrhoea—Fluorouracil—head and neck cancer	0.000495	0.00146	CcSEcCtD
Sertraline—Hypotension—Docetaxel—head and neck cancer	0.000488	0.00144	CcSEcCtD
Sertraline—Dizziness—Fluorouracil—head and neck cancer	0.000478	0.00142	CcSEcCtD
Sertraline—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.000476	0.00141	CcSEcCtD
Sertraline—Insomnia—Docetaxel—head and neck cancer	0.000472	0.0014	CcSEcCtD
Sertraline—Paraesthesia—Docetaxel—head and neck cancer	0.000469	0.00139	CcSEcCtD
Sertraline—Dyspnoea—Docetaxel—head and neck cancer	0.000465	0.00138	CcSEcCtD
Sertraline—Somnolence—Docetaxel—head and neck cancer	0.000464	0.00137	CcSEcCtD
Sertraline—Vomiting—Fluorouracil—head and neck cancer	0.00046	0.00136	CcSEcCtD
Sertraline—Dyspepsia—Docetaxel—head and neck cancer	0.000459	0.00136	CcSEcCtD
Sertraline—Rash—Fluorouracil—head and neck cancer	0.000456	0.00135	CcSEcCtD
Sertraline—Dermatitis—Fluorouracil—head and neck cancer	0.000456	0.00135	CcSEcCtD
Sertraline—Decreased appetite—Docetaxel—head and neck cancer	0.000454	0.00134	CcSEcCtD
Sertraline—Headache—Fluorouracil—head and neck cancer	0.000453	0.00134	CcSEcCtD
Sertraline—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.000451	0.00133	CcSEcCtD
Sertraline—Fatigue—Docetaxel—head and neck cancer	0.00045	0.00133	CcSEcCtD
Sertraline—Constipation—Docetaxel—head and neck cancer	0.000446	0.00132	CcSEcCtD
Sertraline—Pain—Docetaxel—head and neck cancer	0.000446	0.00132	CcSEcCtD
Sertraline—Feeling abnormal—Docetaxel—head and neck cancer	0.00043	0.00127	CcSEcCtD
Sertraline—Nausea—Fluorouracil—head and neck cancer	0.00043	0.00127	CcSEcCtD
Sertraline—Gastrointestinal pain—Docetaxel—head and neck cancer	0.000427	0.00126	CcSEcCtD
Sertraline—Abdominal pain—Docetaxel—head and neck cancer	0.000413	0.00122	CcSEcCtD
Sertraline—Body temperature increased—Docetaxel—head and neck cancer	0.000413	0.00122	CcSEcCtD
Sertraline—Hypersensitivity—Docetaxel—head and neck cancer	0.000385	0.00114	CcSEcCtD
Sertraline—Asthenia—Docetaxel—head and neck cancer	0.000375	0.00111	CcSEcCtD
Sertraline—Pruritus—Docetaxel—head and neck cancer	0.000369	0.00109	CcSEcCtD
Sertraline—Diarrhoea—Docetaxel—head and neck cancer	0.000357	0.00106	CcSEcCtD
Sertraline—Dizziness—Docetaxel—head and neck cancer	0.000345	0.00102	CcSEcCtD
Sertraline—Vomiting—Docetaxel—head and neck cancer	0.000332	0.000983	CcSEcCtD
Sertraline—Rash—Docetaxel—head and neck cancer	0.000329	0.000974	CcSEcCtD
Sertraline—Dermatitis—Docetaxel—head and neck cancer	0.000329	0.000973	CcSEcCtD
Sertraline—Headache—Docetaxel—head and neck cancer	0.000327	0.000968	CcSEcCtD
Sertraline—Nausea—Docetaxel—head and neck cancer	0.00031	0.000918	CcSEcCtD
Sertraline—CYP3A4—Estrogen metabolism—CYP1A1—head and neck cancer	0.000277	0.00672	CbGpPWpGaD
Sertraline—MAOB—Biological oxidations—GSTM1—head and neck cancer	0.000269	0.00653	CbGpPWpGaD
Sertraline—MAOB—Biological oxidations—CYP1A1—head and neck cancer	0.000255	0.00619	CbGpPWpGaD
Sertraline—CYP3A4—Xenobiotics—CYP1A1—head and neck cancer	0.000255	0.00618	CbGpPWpGaD
Sertraline—CYP1A2—Melatonin metabolism and effects—CYP1A1—head and neck cancer	0.000245	0.00595	CbGpPWpGaD
Sertraline—CYP3A4—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000245	0.00594	CbGpPWpGaD
Sertraline—SLC6A4—NRF2 pathway—GSTM1—head and neck cancer	0.000235	0.0057	CbGpPWpGaD
Sertraline—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000233	0.00565	CbGpPWpGaD
Sertraline—CYP2B6—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.00023	0.00557	CbGpPWpGaD
Sertraline—MAOB—Metabolism—UROD—head and neck cancer	0.000224	0.00544	CbGpPWpGaD
Sertraline—CYP1A2—Estrogen Receptor Pathway—STAT3—head and neck cancer	0.000216	0.00524	CbGpPWpGaD
Sertraline—CYP1A2—Phase II conjugation—NAT2—head and neck cancer	0.000216	0.00523	CbGpPWpGaD
Sertraline—CYP2B6—Biological oxidations—NAT2—head and neck cancer	0.000214	0.00519	CbGpPWpGaD
Sertraline—CYP2B6—Metapathway biotransformation—NAT2—head and neck cancer	0.000211	0.00512	CbGpPWpGaD
Sertraline—CYP2C19—Arachidonic acid metabolism—GPX1—head and neck cancer	0.000206	0.00499	CbGpPWpGaD
Sertraline—CYP2C19—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.000204	0.00494	CbGpPWpGaD
Sertraline—SLC6A2—NRF2 pathway—GSTM1—head and neck cancer	0.000202	0.0049	CbGpPWpGaD
Sertraline—CYP2B6—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000189	0.00458	CbGpPWpGaD
Sertraline—CYP2C9—Arachidonic acid metabolism—GPX1—head and neck cancer	0.000188	0.00455	CbGpPWpGaD
Sertraline—CYP2C9—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.000186	0.0045	CbGpPWpGaD
Sertraline—SLC6A4—Circadian rythm related genes—TYMS—head and neck cancer	0.000184	0.00446	CbGpPWpGaD
Sertraline—SLC6A3—NRF2 pathway—GSTM1—head and neck cancer	0.000179	0.00434	CbGpPWpGaD
Sertraline—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000176	0.00427	CbGpPWpGaD
Sertraline—CYP2C19—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000174	0.00421	CbGpPWpGaD
Sertraline—CYP1A2—Tryptophan metabolism—CYP1A1—head and neck cancer	0.00017	0.00411	CbGpPWpGaD
Sertraline—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—head and neck cancer	0.00017	0.00411	CbGpPWpGaD
Sertraline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—head and neck cancer	0.00017	0.00411	CbGpPWpGaD
Sertraline—MAOA—Biological oxidations—GSTM1—head and neck cancer	0.000169	0.00409	CbGpPWpGaD
Sertraline—SLC6A2—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000166	0.00402	CbGpPWpGaD
Sertraline—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000162	0.00392	CbGpPWpGaD
Sertraline—CYP2C19—Biological oxidations—NAT2—head and neck cancer	0.000162	0.00392	CbGpPWpGaD
Sertraline—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.00016	0.00389	CbGpPWpGaD
Sertraline—CYP1A2—Arachidonic acid metabolism—GPX1—head and neck cancer	0.00016	0.00389	CbGpPWpGaD
Sertraline—MAOA—Biological oxidations—CYP1A1—head and neck cancer	0.00016	0.00388	CbGpPWpGaD
Sertraline—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.00016	0.00387	CbGpPWpGaD
Sertraline—CYP2C19—Metapathway biotransformation—NAT2—head and neck cancer	0.00016	0.00387	CbGpPWpGaD
Sertraline—CYP1A2—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.000159	0.00385	CbGpPWpGaD
Sertraline—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000158	0.00384	CbGpPWpGaD
Sertraline—CYP2D6—Biological oxidations—NAT2—head and neck cancer	0.000149	0.00361	CbGpPWpGaD
Sertraline—CYP2C9—Biological oxidations—NAT2—head and neck cancer	0.000148	0.00358	CbGpPWpGaD
Sertraline—CYP2D6—Metapathway biotransformation—NAT2—head and neck cancer	0.000147	0.00356	CbGpPWpGaD
Sertraline—SLC6A3—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000147	0.00356	CbGpPWpGaD
Sertraline—CYP2C9—Metapathway biotransformation—NAT2—head and neck cancer	0.000146	0.00353	CbGpPWpGaD
Sertraline—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000143	0.00346	CbGpPWpGaD
Sertraline—MAOA—Metabolism—UROD—head and neck cancer	0.000141	0.00341	CbGpPWpGaD
Sertraline—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000137	0.00332	CbGpPWpGaD
Sertraline—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000135	0.00328	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—RARB—head and neck cancer	0.000133	0.00322	CbGpPWpGaD
Sertraline—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000131	0.00318	CbGpPWpGaD
Sertraline—CYP3A4—Tryptophan metabolism—CYP1A1—head and neck cancer	0.000131	0.00317	CbGpPWpGaD
Sertraline—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.00013	0.00315	CbGpPWpGaD
Sertraline—CYP1A2—Biological oxidations—NAT2—head and neck cancer	0.000126	0.00306	CbGpPWpGaD
Sertraline—CYP1A2—Metapathway biotransformation—NAT2—head and neck cancer	0.000124	0.00302	CbGpPWpGaD
Sertraline—CYP2C19—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.000121	0.00294	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—RAD51—head and neck cancer	0.000121	0.00293	CbGpPWpGaD
Sertraline—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000111	0.0027	CbGpPWpGaD
Sertraline—CYP2C9—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.00011	0.00268	CbGpPWpGaD
Sertraline—CYP1A2—Phase II conjugation—GSTM1—head and neck cancer	0.000106	0.00258	CbGpPWpGaD
Sertraline—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000106	0.00257	CbGpPWpGaD
Sertraline—CYP2B6—Biological oxidations—GSTM1—head and neck cancer	0.000106	0.00257	CbGpPWpGaD
Sertraline—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000104	0.00253	CbGpPWpGaD
Sertraline—CYP2B6—Metapathway biotransformation—GSTM1—head and neck cancer	0.000104	0.00253	CbGpPWpGaD
Sertraline—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—head and neck cancer	0.000101	0.00245	CbGpPWpGaD
Sertraline—ABCB1—Allograft Rejection—CASP8—head and neck cancer	0.000101	0.00244	CbGpPWpGaD
Sertraline—CYP2B6—Biological oxidations—CYP1A1—head and neck cancer	0.0001	0.00243	CbGpPWpGaD
Sertraline—SLC6A4—SIDS Susceptibility Pathways—VEGFA—head and neck cancer	9.89e-05	0.0024	CbGpPWpGaD
Sertraline—CYP2B6—Metapathway biotransformation—CYP1A1—head and neck cancer	9.89e-05	0.0024	CbGpPWpGaD
Sertraline—CYP3A4—Biological oxidations—NAT2—head and neck cancer	9.73e-05	0.00236	CbGpPWpGaD
Sertraline—CYP3A4—Metapathway biotransformation—NAT2—head and neck cancer	9.6e-05	0.00233	CbGpPWpGaD
Sertraline—CYP1A2—Arachidonic acid metabolism—PTGS2—head and neck cancer	9.43e-05	0.00229	CbGpPWpGaD
Sertraline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—head and neck cancer	9.35e-05	0.00227	CbGpPWpGaD
Sertraline—MAOB—Metabolism—NAT2—head and neck cancer	9.32e-05	0.00226	CbGpPWpGaD
Sertraline—SLC6A4—Circadian rythm related genes—PTEN—head and neck cancer	8.94e-05	0.00217	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—UROD—head and neck cancer	8.82e-05	0.00214	CbGpPWpGaD
Sertraline—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	8.58e-05	0.00208	CbGpPWpGaD
Sertraline—MAOB—Metabolism—DPYD—head and neck cancer	8.17e-05	0.00198	CbGpPWpGaD
Sertraline—MAOA—SIDS Susceptibility Pathways—VEGFA—head and neck cancer	8.11e-05	0.00197	CbGpPWpGaD
Sertraline—CYP2C19—Biological oxidations—GSTM1—head and neck cancer	7.99e-05	0.00194	CbGpPWpGaD
Sertraline—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—head and neck cancer	7.94e-05	0.00193	CbGpPWpGaD
Sertraline—CYP2C19—Metapathway biotransformation—GSTM1—head and neck cancer	7.88e-05	0.00191	CbGpPWpGaD
Sertraline—MAOB—Metabolism—YAP1—head and neck cancer	7.75e-05	0.00188	CbGpPWpGaD
Sertraline—ABCB1—Allograft Rejection—IL2—head and neck cancer	7.6e-05	0.00184	CbGpPWpGaD
Sertraline—CYP2C19—Biological oxidations—CYP1A1—head and neck cancer	7.58e-05	0.00184	CbGpPWpGaD
Sertraline—CYP2C19—Metapathway biotransformation—CYP1A1—head and neck cancer	7.47e-05	0.00181	CbGpPWpGaD
Sertraline—ABCB1—HIF-1-alpha transcription factor network—VEGFA—head and neck cancer	7.45e-05	0.00181	CbGpPWpGaD
Sertraline—CYP2D6—Biological oxidations—GSTM1—head and neck cancer	7.35e-05	0.00178	CbGpPWpGaD
Sertraline—ABCB1—Transmembrane transport of small molecules—ATP7B—head and neck cancer	7.3e-05	0.00177	CbGpPWpGaD
Sertraline—CYP2C9—Biological oxidations—GSTM1—head and neck cancer	7.29e-05	0.00177	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—head and neck cancer	7.26e-05	0.00176	CbGpPWpGaD
Sertraline—CYP2D6—Metapathway biotransformation—GSTM1—head and neck cancer	7.25e-05	0.00176	CbGpPWpGaD
Sertraline—CYP2C9—Metapathway biotransformation—GSTM1—head and neck cancer	7.19e-05	0.00174	CbGpPWpGaD
Sertraline—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—head and neck cancer	7.15e-05	0.00173	CbGpPWpGaD
Sertraline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—head and neck cancer	7.15e-05	0.00173	CbGpPWpGaD
Sertraline—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—head and neck cancer	7.15e-05	0.00173	CbGpPWpGaD
Sertraline—CYP2D6—Biological oxidations—CYP1A1—head and neck cancer	6.97e-05	0.00169	CbGpPWpGaD
Sertraline—CYP2C9—Biological oxidations—CYP1A1—head and neck cancer	6.91e-05	0.00168	CbGpPWpGaD
Sertraline—CYP2D6—Metapathway biotransformation—CYP1A1—head and neck cancer	6.87e-05	0.00167	CbGpPWpGaD
Sertraline—CYP2C9—Metapathway biotransformation—CYP1A1—head and neck cancer	6.81e-05	0.00165	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—UROD—head and neck cancer	6.66e-05	0.00162	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—UROD—head and neck cancer	6.5e-05	0.00158	CbGpPWpGaD
Sertraline—ABCB1—Allograft Rejection—VEGFA—head and neck cancer	6.46e-05	0.00157	CbGpPWpGaD
Sertraline—CYP1A2—Biological oxidations—GSTM1—head and neck cancer	6.23e-05	0.00151	CbGpPWpGaD
Sertraline—CYP1A2—Metapathway biotransformation—GSTM1—head and neck cancer	6.14e-05	0.00149	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—UROD—head and neck cancer	6.13e-05	0.00149	CbGpPWpGaD
Sertraline—SLC6A4—Circadian rythm related genes—TP53—head and neck cancer	6.1e-05	0.00148	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—UROD—head and neck cancer	6.08e-05	0.00147	CbGpPWpGaD
Sertraline—MAOA—Transmission across Chemical Synapses—MAPK1—head and neck cancer	5.98e-05	0.00145	CbGpPWpGaD
Sertraline—CYP1A2—Biological oxidations—CYP1A1—head and neck cancer	5.9e-05	0.00143	CbGpPWpGaD
Sertraline—MAOA—Metabolism—NAT2—head and neck cancer	5.85e-05	0.00142	CbGpPWpGaD
Sertraline—CYP1A2—Metapathway biotransformation—CYP1A1—head and neck cancer	5.82e-05	0.00141	CbGpPWpGaD
Sertraline—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—head and neck cancer	5.74e-05	0.00139	CbGpPWpGaD
Sertraline—SLC6A3—Transmission across Chemical Synapses—MAPK1—head and neck cancer	5.56e-05	0.00135	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—UROD—head and neck cancer	5.19e-05	0.00126	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	5.17e-05	0.00125	CbGpPWpGaD
Sertraline—MAOA—Metabolism—DPYD—head and neck cancer	5.13e-05	0.00124	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—head and neck cancer	4.96e-05	0.0012	CbGpPWpGaD
Sertraline—MAOA—Metabolism—YAP1—head and neck cancer	4.86e-05	0.00118	CbGpPWpGaD
Sertraline—CYP3A4—Biological oxidations—GSTM1—head and neck cancer	4.81e-05	0.00117	CbGpPWpGaD
Sertraline—MAOA—Transmission across Chemical Synapses—HRAS—head and neck cancer	4.8e-05	0.00116	CbGpPWpGaD
Sertraline—ABCB1—HIF-1-alpha transcription factor network—AKT1—head and neck cancer	4.76e-05	0.00115	CbGpPWpGaD
Sertraline—CYP3A4—Metapathway biotransformation—GSTM1—head and neck cancer	4.74e-05	0.00115	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	4.71e-05	0.00114	CbGpPWpGaD
Sertraline—MAOB—Metabolism—TYMS—head and neck cancer	4.66e-05	0.00113	CbGpPWpGaD
Sertraline—MAOB—Metabolism—GSTM1—head and neck cancer	4.6e-05	0.00112	CbGpPWpGaD
Sertraline—MAOA—Neuronal System—MAPK1—head and neck cancer	4.58e-05	0.00111	CbGpPWpGaD
Sertraline—CYP3A4—Biological oxidations—CYP1A1—head and neck cancer	4.56e-05	0.0011	CbGpPWpGaD
Sertraline—CYP3A4—Metapathway biotransformation—CYP1A1—head and neck cancer	4.49e-05	0.00109	CbGpPWpGaD
Sertraline—SLC6A3—Transmission across Chemical Synapses—HRAS—head and neck cancer	4.46e-05	0.00108	CbGpPWpGaD
Sertraline—MAOB—Metabolism—GPX1—head and neck cancer	4.41e-05	0.00107	CbGpPWpGaD
Sertraline—MAOB—Metabolism—CYP1A1—head and neck cancer	4.36e-05	0.00106	CbGpPWpGaD
Sertraline—SLC6A3—Neuronal System—MAPK1—head and neck cancer	4.26e-05	0.00103	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	4.26e-05	0.00103	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—head and neck cancer	4.04e-05	0.000981	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	4.03e-05	0.000977	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—UROD—head and neck cancer	4.01e-05	0.000972	CbGpPWpGaD
Sertraline—MAOA—Neuronal System—HRAS—head and neck cancer	3.68e-05	0.000892	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—NAT2—head and neck cancer	3.66e-05	0.000888	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	3.65e-05	0.000886	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	3.53e-05	0.000855	CbGpPWpGaD
Sertraline—SLC6A3—Neuronal System—HRAS—head and neck cancer	3.42e-05	0.000829	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—DPYD—head and neck cancer	3.21e-05	0.000779	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	3.19e-05	0.000773	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—YAP1—head and neck cancer	3.05e-05	0.000739	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	3.01e-05	0.000731	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	2.94e-05	0.000713	CbGpPWpGaD
Sertraline—MAOA—Metabolism—TYMS—head and neck cancer	2.92e-05	0.000708	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	2.91e-05	0.000706	CbGpPWpGaD
Sertraline—MAOA—Metabolism—GSTM1—head and neck cancer	2.89e-05	0.0007	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	2.87e-05	0.000695	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	2.87e-05	0.000695	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—NAT2—head and neck cancer	2.77e-05	0.000671	CbGpPWpGaD
Sertraline—MAOA—Metabolism—GPX1—head and neck cancer	2.77e-05	0.000671	CbGpPWpGaD
Sertraline—MAOA—Metabolism—CYP1A1—head and neck cancer	2.74e-05	0.000664	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—NAT2—head and neck cancer	2.7e-05	0.000655	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	2.68e-05	0.00065	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	2.65e-05	0.000643	CbGpPWpGaD
Sertraline—MAOB—Metabolism—PTGS2—head and neck cancer	2.59e-05	0.000629	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—NAT2—head and neck cancer	2.55e-05	0.000617	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—NAT2—head and neck cancer	2.52e-05	0.000612	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	2.49e-05	0.000603	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—DPYD—head and neck cancer	2.43e-05	0.000589	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	2.41e-05	0.000584	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—DPYD—head and neck cancer	2.37e-05	0.000574	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—YAP1—head and neck cancer	2.3e-05	0.000558	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	2.29e-05	0.000555	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	2.27e-05	0.00055	CbGpPWpGaD
Sertraline—MAOB—Metabolism—PTEN—head and neck cancer	2.26e-05	0.000549	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—YAP1—head and neck cancer	2.25e-05	0.000545	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—DPYD—head and neck cancer	2.23e-05	0.000541	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—DPYD—head and neck cancer	2.21e-05	0.000537	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—NAT2—head and neck cancer	2.16e-05	0.000523	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—YAP1—head and neck cancer	2.12e-05	0.000514	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—YAP1—head and neck cancer	2.1e-05	0.000509	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	2.03e-05	0.000493	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—DPYD—head and neck cancer	1.89e-05	0.000459	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—TYMS—head and neck cancer	1.83e-05	0.000444	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—GSTM1—head and neck cancer	1.81e-05	0.000439	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—YAP1—head and neck cancer	1.79e-05	0.000435	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—GPX1—head and neck cancer	1.73e-05	0.00042	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	1.73e-05	0.00042	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—CYP1A1—head and neck cancer	1.71e-05	0.000416	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—NAT2—head and neck cancer	1.66e-05	0.000404	CbGpPWpGaD
Sertraline—MAOA—Metabolism—PTGS2—head and neck cancer	1.63e-05	0.000395	CbGpPWpGaD
Sertraline—MAOB—Metabolism—PIK3CA—head and neck cancer	1.6e-05	0.000387	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	1.58e-05	0.000383	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.51e-05	0.000366	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—DPYD—head and neck cancer	1.46e-05	0.000354	CbGpPWpGaD
Sertraline—MAOA—Metabolism—PTEN—head and neck cancer	1.42e-05	0.000344	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—YAP1—head and neck cancer	1.38e-05	0.000336	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—TYMS—head and neck cancer	1.38e-05	0.000335	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.38e-05	0.000334	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—GSTM1—head and neck cancer	1.37e-05	0.000331	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—TYMS—head and neck cancer	1.35e-05	0.000327	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	1.35e-05	0.000327	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—GSTM1—head and neck cancer	1.33e-05	0.000324	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—GPX1—head and neck cancer	1.31e-05	0.000317	CbGpPWpGaD
Sertraline—MAOB—Metabolism—AKT1—head and neck cancer	1.3e-05	0.000316	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—CYP1A1—head and neck cancer	1.3e-05	0.000314	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—GPX1—head and neck cancer	1.28e-05	0.00031	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—TYMS—head and neck cancer	1.27e-05	0.000308	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—CYP1A1—head and neck cancer	1.26e-05	0.000307	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—TYMS—head and neck cancer	1.26e-05	0.000306	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—GSTM1—head and neck cancer	1.26e-05	0.000305	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—GSTM1—head and neck cancer	1.25e-05	0.000302	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—GPX1—head and neck cancer	1.2e-05	0.000292	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—GPX1—head and neck cancer	1.19e-05	0.000289	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—CYP1A1—head and neck cancer	1.19e-05	0.000289	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—CYP1A1—head and neck cancer	1.18e-05	0.000287	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.18e-05	0.000285	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—TYMS—head and neck cancer	1.08e-05	0.000261	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—GSTM1—head and neck cancer	1.06e-05	0.000258	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.06e-05	0.000258	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—GPX1—head and neck cancer	1.02e-05	0.000247	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—PTGS2—head and neck cancer	1.02e-05	0.000247	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—CYP1A1—head and neck cancer	1.01e-05	0.000245	CbGpPWpGaD
Sertraline—MAOA—Metabolism—PIK3CA—head and neck cancer	1e-05	0.000243	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	9.71e-06	0.000235	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—PTEN—head and neck cancer	8.89e-06	0.000216	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—TYMS—head and neck cancer	8.31e-06	0.000202	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	8.29e-06	0.000201	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—GSTM1—head and neck cancer	8.22e-06	0.000199	CbGpPWpGaD
Sertraline—MAOA—Metabolism—AKT1—head and neck cancer	8.18e-06	0.000198	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—GPX1—head and neck cancer	7.87e-06	0.000191	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—CYP1A1—head and neck cancer	7.79e-06	0.000189	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—PTGS2—head and neck cancer	7.71e-06	0.000187	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—PTGS2—head and neck cancer	7.52e-06	0.000182	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—PTGS2—head and neck cancer	7.09e-06	0.000172	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—PTGS2—head and neck cancer	7.03e-06	0.00017	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—PTEN—head and neck cancer	6.72e-06	0.000163	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—PTEN—head and neck cancer	6.56e-06	0.000159	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—PIK3CA—head and neck cancer	6.27e-06	0.000152	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—PTEN—head and neck cancer	6.18e-06	0.00015	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—PTEN—head and neck cancer	6.13e-06	0.000149	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—PTGS2—head and neck cancer	6e-06	0.000146	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—PTEN—head and neck cancer	5.24e-06	0.000127	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—AKT1—head and neck cancer	5.12e-06	0.000124	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—PIK3CA—head and neck cancer	4.74e-06	0.000115	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—PTGS2—head and neck cancer	4.63e-06	0.000112	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—PIK3CA—head and neck cancer	4.63e-06	0.000112	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—PIK3CA—head and neck cancer	4.36e-06	0.000106	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—PIK3CA—head and neck cancer	4.32e-06	0.000105	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—PTEN—head and neck cancer	4.04e-06	9.8e-05	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—AKT1—head and neck cancer	3.87e-06	9.39e-05	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—AKT1—head and neck cancer	3.78e-06	9.17e-05	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—PIK3CA—head and neck cancer	3.69e-06	8.96e-05	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—AKT1—head and neck cancer	3.56e-06	8.64e-05	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—AKT1—head and neck cancer	3.53e-06	8.56e-05	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—AKT1—head and neck cancer	3.02e-06	7.32e-05	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—PIK3CA—head and neck cancer	2.85e-06	6.91e-05	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—AKT1—head and neck cancer	2.33e-06	5.65e-05	CbGpPWpGaD
